| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.42B | 23.76B | 24.62B | 25.19B | 24.89B | 24.42B |
| Gross Profit | 3.56B | 3.49B | 3.58B | 3.83B | 3.90B | 3.81B |
| EBITDA | -231.00M | -348.00M | -203.00M | 21.00M | 98.00M | 164.00M |
| Net Income | -392.00M | 317.00M | -640.00M | 150.00M | -1.19B | -718.00M |
Balance Sheet | ||||||
| Total Assets | 12.28B | 12.68B | 12.52B | 13.57B | 13.71B | 14.45B |
| Cash, Cash Equivalents and Short-Term Investments | 1.54B | 2.22B | 1.87B | 2.68B | 2.32B | 2.35B |
| Total Debt | 5.61B | 6.03B | 5.84B | 5.97B | 6.33B | 6.03B |
| Total Liabilities | 10.34B | 10.19B | 10.67B | 11.20B | 11.48B | 11.00B |
| Stockholders Equity | 1.94B | 2.49B | 1.85B | 2.37B | 2.23B | 3.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.18B | -544.00M | -589.00M | -394.00M | -194.00M |
| Operating Cash Flow | 0.00 | -763.00M | -239.00M | -178.00M | -49.00M | 205.00M |
| Investing Cash Flow | 0.00 | 953.00M | -354.00M | 909.00M | -278.00M | -198.00M |
| Financing Cash Flow | 0.00 | 164.00M | -220.00M | -366.00M | 292.00M | -337.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥55.99B | 5.55 | 6.48% | 2.27% | 1.46% | 80.77% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥540.07B | 19.54 | 9.86% | 2.58% | 2.00% | 12.21% | |
57 Neutral | ¥255.26B | 13.51 | ― | 2.61% | 8.35% | 54.38% | |
56 Neutral | ¥567.52B | 14.32 | 6.04% | 2.04% | 6.34% | 38.64% | |
45 Neutral | ¥1.61B | 5.08 | ― | ― | -3.51% | ― | |
43 Neutral | ¥5.59B | -24.25 | ― | ― | -5.42% | 53.47% |